342 related articles for article (PubMed ID: 19362372)
1. Role of phosphoinositide 3-kinase p110 delta in TLR4- and TLR9-mediated B cell cytokine production and differentiation.
Dil N; Marshall AJ
Mol Immunol; 2009 Jun; 46(10):1970-8. PubMed ID: 19362372
[TBL] [Abstract][Full Text] [Related]
2. Selective synergy in anti-inflammatory cytokine production upon cooperated signaling via TLR4 and TLR2 in murine conventional dendritic cells.
Hirata N; Yanagawa Y; Ebihara T; Seya T; Uematsu S; Akira S; Hayashi F; Iwabuchi K; Onoé K
Mol Immunol; 2008 May; 45(10):2734-42. PubMed ID: 18372043
[TBL] [Abstract][Full Text] [Related]
3. PI3K is a negative regulator of IgE production.
Doi T; Obayashi K; Kadowaki T; Fujii H; Koyasu S
Int Immunol; 2008 Apr; 20(4):499-508. PubMed ID: 18303010
[TBL] [Abstract][Full Text] [Related]
4. TLR4, TLR9 and MyD88 are not required for the positive selection of autoreactive B cells into the primary repertoire.
Silver K; Ferry H; Crockford T; Cornall RJ
Eur J Immunol; 2006 Jun; 36(6):1404-12. PubMed ID: 16703567
[TBL] [Abstract][Full Text] [Related]
5. IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production.
Giordani L; Sanchez M; Libri I; Quaranta MG; Mattioli B; Viora M
J Leukoc Biol; 2009 Aug; 86(2):261-71. PubMed ID: 19401392
[TBL] [Abstract][Full Text] [Related]
6. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.
Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P
Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171
[TBL] [Abstract][Full Text] [Related]
7. CC chemokine ligand 17 in periodontal diseases: expression in diseased tissues and production by human gingival fibroblasts.
Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Matsuo T
J Periodontal Res; 2008 Aug; 43(4):471-7. PubMed ID: 18557811
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 7 cooperates with IL-4 in activated B cells through antigen receptor or CD38 and induces class switch recombination and IgG1 production.
Tsukamoto Y; Nagai Y; Kariyone A; Shibata T; Kaisho T; Akira S; Miyake K; Takatsu K
Mol Immunol; 2009 Apr; 46(7):1278-88. PubMed ID: 19157556
[TBL] [Abstract][Full Text] [Related]
9. CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells.
Liu N; Ohnishi N; Ni L; Akira S; Bacon KB
Nat Immunol; 2003 Jul; 4(7):687-93. PubMed ID: 12766768
[TBL] [Abstract][Full Text] [Related]
10. CpG ODN mediated prevention from ovalbumin-induced anaphylaxis in mouse through B cell pathway.
Xu W; Tamura T; Takatsu K
Int Immunopharmacol; 2008 Feb; 8(2):351-61. PubMed ID: 18182251
[TBL] [Abstract][Full Text] [Related]
11. TLR9 cooperates with TLR4 to increase IL-12 release by murine dendritic cells.
Theiner G; Rössner S; Dalpke A; Bode K; Berger T; Gessner A; Lutz MB
Mol Immunol; 2008 Jan; 45(1):244-52. PubMed ID: 17599410
[TBL] [Abstract][Full Text] [Related]
12. Effect of synthetic agonists of toll-like receptor 9 on canine lymphocyte proliferation and cytokine production in vitro.
Im Hof M; Williamson L; Summerfield A; Balmer V; Dutoit V; Kandimalla ER; Yu D; Zurbriggen A; Doherr MG; Peel J; Roosje PJ
Vet Immunol Immunopathol; 2008 Jul; 124(1-2):120-31. PubMed ID: 18452997
[TBL] [Abstract][Full Text] [Related]
13. Suppression of B-cell activation and IgE, IgA, IgG1 and IgG4 production by mammalian telomeric oligonucleotides.
Sackesen C; van de Veen W; Akdis M; Soyer O; Zumkehr J; Ruckert B; Stanic B; Kalaycı O; Alkan SS; Gursel I; Akdis CA
Allergy; 2013; 68(5):593-603. PubMed ID: 23480796
[TBL] [Abstract][Full Text] [Related]
14. TOLL-like receptor ligands stimulate aberrant class switch recombination in early B cell precursors.
Edry E; Azulay-Debby H; Melamed D
Int Immunol; 2008 Dec; 20(12):1575-85. PubMed ID: 18974086
[TBL] [Abstract][Full Text] [Related]
15. The human Burkitt lymphoma cell line Namalwa represents a homogenous cell system characterized by high levels of Toll-like receptor 9 and activation by CpG oligonucleotides.
Henault M; Lee LN; Evans GF; Zuckerman SH
J Immunol Methods; 2005 May; 300(1-2):93-9. PubMed ID: 15894327
[TBL] [Abstract][Full Text] [Related]
16. Phosphatidylinositol 3-kinase-mediated regulation of IL-10 and IL-12 production in macrophages stimulated with CpG oligodeoxynucleotide.
Saegusa K; Yotsumoto S; Kato S; Aramaki Y
Mol Immunol; 2007 Feb; 44(6):1323-30. PubMed ID: 16824602
[TBL] [Abstract][Full Text] [Related]
17. Defective Toll-like receptor 9-mediated cytokine production in B cells from Bruton's tyrosine kinase-deficient mice.
Hasan M; Lopez-Herrera G; Blomberg KE; Lindvall JM; Berglöf A; Smith CI; Vargas L
Immunology; 2008 Feb; 123(2):239-49. PubMed ID: 17725607
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 7-induced naive human B-cell differentiation and immunoglobulin production.
Glaum MC; Narula S; Song D; Zheng Y; Anderson AL; Pletcher CH; Levinson AI
J Allergy Clin Immunol; 2009 Jan; 123(1):224-230.e4. PubMed ID: 18995892
[TBL] [Abstract][Full Text] [Related]
19. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
[TBL] [Abstract][Full Text] [Related]
20. Synergistic augmentation of inflammatory cytokine productions from murine mast cells by monomeric IgE and toll-like receptor ligands.
Takenaka H; Ushio H; Niyonsaba F; Jayawardana ST; Hajime S; Ikeda S; Ogawa H; Okumura K
Biochem Biophys Res Commun; 2010 Jan; 391(1):471-6. PubMed ID: 19914211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
